Tier A

Beta-Glucan (β-glucan · cereal + yeast variants)

Also known as: β-1,3-glucan · (1,3/1,6)-β-D-glucan · Oat β-glucan · Yeast β-glucan

31 PMID anchor · CARDIO · IMMUNE · GUT · Last reviewed 2026-05-31

Mechanism of action

  • Cereal: bile acid binding · cholesterol-lowering
  • Yeast: Dectin-1 receptor immune training · AHCC pathway

Molecular + tissue targets

  • LDL cholesterol (cereal)
  • Innate immune training (yeast)
  • Gut microbiome

Dosage range

Cereal: ≥ 3 g/day for cholesterol effect (FDA + EFSA dual-authorized · ANVISA Anexo I authorized constituent without alegação funcional); Yeast: 250-500 mg/day in emerging immune RCTs

Safety notes

Generally well tolerated; cereal β-glucan negative trial (Ibrügger 2013) disclosed; yeast β-glucan long-term data limited

Cross-market regulatory status

🇺🇸 FDA

Authorized health claim (oat β-glucan + CHD · 21 CFR 101.81)

🇪🇺 EFSA

Authorized claim (oat + barley β-glucan + cholesterol maintenance)

🇧🇷 ANVISA

RDC 243/2018 dietary supplement framework · IN 28/2018 Anexo I authorized constituent (Beta-glucana de farelo de aveia · Beta-glucana de levedura) · NO Anexo V alegação funcional for beta-glucan (Anexo V fiber claims limited to psyllium ≥ 7 g/dia and quitosana ≥ 3 g/dia)

Authorized claims · verbatim (4)

Direct quotes from each jurisdiction's framework · never paraphrased · with framework reference and conditions of use.

🇺🇸 FDA · 1 claim

21 CFR 101.81 Authorized Health Claim

Soluble fiber from oats, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the [necessary daily dietary intake of] beta-glucan soluble fiber from oats necessary per day to have this effect.

Conditions: ≥ 3 g/day β-glucan from whole oats or oat bran

Authorized 1997

🇪🇺 EFSA · 3 claims

Reg 432/2012

Oat beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease.

Conditions: ≥ 3 g/day oat β-glucan

Authorized 2012

Reg 432/2012

Barley beta-glucan has been shown to lower/reduce blood cholesterol.

Conditions: ≥ 3 g/day barley β-glucan

Authorized 2012

Reg 432/2012

Beta-glucans contribute to the maintenance of normal blood cholesterol levels.

Conditions: ≥ 1 g/day β-glucan from oats/barley

Authorized 2012

Common use cases

  • cholesterol management (cereal β-glucan)
  • immune support (yeast β-glucan · emerging)
Ask Agent Axor